New York Medical Marijuana Law

Status

Operational

Law Signed:

2014

QUALIFYING CONDITIONS

Acute pain management
Amyotrophic Lateral Sclerosis (ALS)
Cancer
Chronic pain
Epilepsy
HIV/AIDS
Huntington’s Disease
Inflammatory bowel disease
Parkinson’s Disease
Post-Traumatic Stress Disorder
Multiple Sclerosis
Neuropathies
Opioid substitution
Spinal cord damage

PATIENT POSSESSION LIMITS

As initially implemented, the law permits qualified patients to possess a 30 day supply of cannabis-infused, non-smokable products. but only non-smokable preparations allowed. Regulations announced by the Department of Health in 2017 state, “[R]egistered organizations will be allowed to manufacture and distribute additional products including topicals such as lotions, ointments and patches, as well as solid and semi-solid products including chewable and effervescent tablets and lozenges. Certain non-smokable forms of ground plant material will also be permissible for manufacture and distribution.” Legislation signed into law in 2021 amended these rules to permit qualified patients to possess a 60-day supply of cannabis and removed the prior prohibitions on smoking.

HOME CULTIVATION

STATE-LICENSED DISPENSARIES

Yes, as initially enacted, five producers of cannabis-based preparations and up to 20 dispensing centers were to be licensed by the state. In 2017, the Department of Health registered five additional entities to manufacture and dispense cannabis-infused products.